Faculty of Pharmacy and Pharmaceutical Sciences

Monash University

Undergraduate - Unit

This unit entry is for students who completed this unit in 2015 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedMalaysia Second semester 2015 (Day)
Parkville Second semester 2015 (Day)
Coordinator(s)Associate Professor Simon Bell (Parkville); Dr Chooi Yeng Lee (Malaysia)


This unit provides an introduction to disease state management. It will cover concepts that span the range of diseases such as issues related to the management of paediatric and geriatric patients and the use and interpretation of laboratory tests for diagnosis and monitoring.

This unit provides a foundation of basic knowledge required for the diagnosis and management of patients with cardiovascular diseases. It will relate the pathophysiology of these disorders with the rational design and clinical use of drugs. The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.

This will involve:

  • introduction to disease state management
  • epidemiology and pathophysiology of cardiovascular disease
  • chemistry of drugs used in cardiovascular disease
  • pharmacology of drugs used in cardiovascular disease
  • cardiovascular disease state management.


At the end of this unit students will be able to:

  1. Describe the epidemiology and concepts of disease state management of cardiovascular diseases including the concepts affecting the management of various types of patients (e.g. paediatric and geriatric patients);
  2. Evaluate a patient's laboratory test results to assist with the diagnosis or management of disease;
  3. Describe the normal function of the cardiovascular system and the signs and symptoms likely to be seen in patients with the disorders;
  4. Recognise when referral for medical assessment is required with a particular emphasis on cardinal symptoms;
  5. Relate modifications of physiological and molecular mechanisms to the observed disorder;
  6. Describe the chemistry of the different types of drugs used to treat these disorders and the chemical and biological principals behind the development of a range of drugs used to treat these disorders;
  7. Describe drug and non-drug therapy options for the management of cardiovascular disease and primary and secondary prevention strategies for cardiovascular disease;
  8. Evaluate a patient's disease state, identify any drug therapy problems and recommend appropriate resolutions of those problems;
  9. Formulate a medical management program for specific patients based on their medical, medication and psychosocial histories and laboratory test results;
  10. Apply basic counselling strategies that optimize behavioural change support for patients with chronic conditions.


Problem based learning tutorials 15%; Clinical knowledge and skills development 5%; OSCE 20%; Final exam (3 hour) 60%

Workload requirements

Contact hours for on-campus students:

  • Thirty six 1-hour lectures
  • One 2-hour practical class
  • Two 3 hour practical classes

See also Unit timetable information

Chief examiner(s)


PAC2182 Basis of drug action II

Additional information on this unit is available from the faculty at: